256 related articles for article (PubMed ID: 21959681)
1. Choroidal neovascularization of optic disk melanocytoma treated with bevacizumab.
Kamisasanuk T; Uchino E; Sakamoto T
Eur J Ophthalmol; 2012; 22(3):503-5. PubMed ID: 21959681
[TBL] [Abstract][Full Text] [Related]
2. Peripapillary choroidal neovascularization associated with melanocytoma of the optic disc: a clinicopathologic case report.
Tran HV; Bovey EH; Uffer S; Zografos L
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1367-9. PubMed ID: 16523299
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child.
Chhablani J; Jalali S
Eur J Ophthalmol; 2012; 22(4):677-9. PubMed ID: 22139615
[TBL] [Abstract][Full Text] [Related]
4. Treatment of macular serous neuroretinal detachment in tilted disk syndrome: report of 3 cases.
Donati MC; Miele A; Abbruzzese G; Giuntoli M; Giansanti F; Menchini U
Eur J Ophthalmol; 2013; 23(2):267-70. PubMed ID: 23225087
[TBL] [Abstract][Full Text] [Related]
5. Multifocal outer retinopathy in a patient with multifocal inner choroidopathy.
Chen FK; Tufail A
Clin Exp Ophthalmol; 2011; 39(7):700-3. PubMed ID: 22452687
[No Abstract] [Full Text] [Related]
6. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
Teixeira A; Mattos T; Velletri R; Teixeira R; Freire J; Moares N; Bonomo PP
Ophthalmic Surg Lasers Imaging; 2010; 41(5):546-9. PubMed ID: 20795575
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial.
Zhang H; Liu ZL; Sun P; Gu F
Am J Ophthalmol; 2012 Feb; 153(2):300-306.e1. PubMed ID: 21982109
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.
Ikuno Y; Sayanagi K; Soga K; Sawa M; Tsujikawa M; Gomi F; Tano Y
Am J Ophthalmol; 2009 Jan; 147(1):94-100.e1. PubMed ID: 18774550
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal ranibizumab injection for idiopathic choroidal neovascularization in children.
Kim R; Kim YC
Semin Ophthalmol; 2014 May; 29(3):178-81. PubMed ID: 24491023
[TBL] [Abstract][Full Text] [Related]
10. Comparison of visual prognoses between natural course of simple hemorrhage and choroidal neovascularization treated with intravitreal bevacizumab in highly myopic eyes: a 1-year follow-up.
Goto S; Sayanagi K; Ikuno Y; Jo Y; Gomi F; Nishida K
Retina; 2015 Mar; 35(3):429-34. PubMed ID: 25166271
[TBL] [Abstract][Full Text] [Related]
11. Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
Sakai T; Ohkuma Y; Kohno H; Hayashi T; Watanabe A; Tsuneoka H
Br J Ophthalmol; 2014 Dec; 98(12):1642-8. PubMed ID: 25053762
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen.
Knape RM; Zavaleta EM; Clark CL; Khuddus N; Peden MC
J AAPOS; 2011 Feb; 15(1):87-90. PubMed ID: 21397813
[TBL] [Abstract][Full Text] [Related]
13. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum.
Finger RP; Charbel Issa P; Schmitz-Valckenberg S; Holz FG; Scholl HN
Retina; 2011; 31(7):1268-78. PubMed ID: 21386758
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
[TBL] [Abstract][Full Text] [Related]
15. Treatment of choroidal neovascularization using intravitreal bevacizumab.
Pedersen R; Soliman W; Lund-Andersen H; Larsen M
Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
[TBL] [Abstract][Full Text] [Related]
16. Combined photodynamic therapy with intravitreal bevacizumab injections for polypoidal choroidal vasculopathy: long-term visual outcome.
Kang HM; Koh HJ; Lee CS; Lee SC
Am J Ophthalmol; 2014 Mar; 157(3):598-606.e1. PubMed ID: 24269378
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.
Rush RB; Rush SW; Aragon AV; Ysasaga JE
Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
[TBL] [Abstract][Full Text] [Related]
19. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
20. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
Mimoun G; Caillaux V; Querques G; Rothschild PR; Puche N; Souied EH
Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]